-
公开(公告)号:US09090671B2
公开(公告)日:2015-07-28
申请号:US12479633
申请日:2009-06-05
申请人: Keqiang Li , Ahmed Mamai , Michael Robert Peel
发明人: Keqiang Li , Ahmed Mamai , Michael Robert Peel
CPC分类号: C07K7/645
摘要: Disclosed are cyclosporine derivatives in which the 3-Sarcosine carbon and 5-Valine nitrogen are each substituted by a non-hydrogen substituent, and their use as pharmaceuticals, in particular for the treatment of hepatitis C virus.
摘要翻译: 公开了其中3-肌氨酸碳和5-缬氨酸氮各自被非氢取代基取代的环孢菌素衍生物,以及它们作为药物的用途,特别是用于治疗丙型肝炎病毒。
-
公开(公告)号:US08222255B2
公开(公告)日:2012-07-17
申请号:US12680472
申请日:2008-09-25
申请人: James M. Balkovec , Phieng Siliphaivanh , Frances A. Bouffard , Roland A. Bouffard, legal representative , Michael R. Peel , Weiming Fan , Ahmed Mamai , Sarah Dimick Gray
发明人: James M. Balkovec , Phieng Siliphaivanh , Frances A. Bouffard , Michael R. Peel , Weiming Fan , Ahmed Mamai , Sarah Dimick Gray
IPC分类号: C07D311/78 , C07D405/02 , A61K31/352 , A61K31/4025 , A61K31/4433 , A61K31/453 , A61K31/496 , A61K31/506 , A61K31/5355
CPC分类号: C07J71/0005
摘要: Novel derivatives of enfumafungin are disclosed herein, along with their, pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.
摘要翻译: 本文公开了enfumafungin的新型衍生物及其药学上可接受的盐,水合物和前药。 还公开了包含这种化合物的组合物,制备这些化合物的方法和使用这些化合物作为抗真菌剂和/或(1,3) - &bgr-D-葡聚糖合酶抑制剂的方法。 所公开的化合物,其药学上可接受的盐,水合物和前药以及包含这些化合物,盐,水合物和前药的组合物可用于治疗和/或预防真菌感染和相关疾病和病症。
-
公开(公告)号:US08188085B2
公开(公告)日:2012-05-29
申请号:US12461318
申请日:2009-08-07
申请人: Mark L. Greenlee , Robert Wilkening , James Apgar , Donald Sperbeck , Kenneth J. Wildonger , Dongfang Meng , Dann L. Parker, Jr. , Gregory J. Pacofsky , Brian H. Heasley , Ahmed Mamai , Kingsley Nelson
发明人: Mark L. Greenlee , Robert Wilkening , James Apgar , Donald Sperbeck , Kenneth J. Wildonger , Dongfang Meng , Dann L. Parker, Jr. , Gregory J. Pacofsky , Brian H. Heasley , Ahmed Mamai , Kingsley Nelson
IPC分类号: A61K31/41 , A61K31/445 , A61K31/501 , C07D231/02 , C07D249/08 , C07D401/00 , C07D401/02 , C07D405/02 , C07D405/14
CPC分类号: A61K31/343 , A01N43/653 , A61K31/21 , A61K31/41 , C07D493/08 , C07D519/00
摘要: Novel derivatives of enfumafungin are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.
摘要翻译: 本文公开了enfumafungin的新型衍生物及其药学上可接受的盐,水合物和前药。 还公开了包含这种化合物的组合物,制备这些化合物的方法和使用这些化合物作为抗真菌剂和/或(1,3) - &bgr-D-葡聚糖合酶抑制剂的方法。 所公开的化合物,其药学上可接受的盐,水合物和前药,以及包含这些化合物,盐,水合物和前药的组合物可用于治疗和/或预防真菌感染和相关疾病和病症。
-
公开(公告)号:US20110224228A1
公开(公告)日:2011-09-15
申请号:US13058227
申请日:2009-08-10
申请人: Mark L Greenlee , Robert Wilkening , James Apgar , Donald Sperbeck , Kenneth J. Wildonger , Dongfang Meng , Dann L. Parker, JR. , Ahmed Mamai
发明人: Mark L Greenlee , Robert Wilkening , James Apgar , Donald Sperbeck , Kenneth J. Wildonger , Dongfang Meng , Dann L. Parker, JR. , Ahmed Mamai
IPC分类号: A61K31/496 , C07D405/08 , C07D405/14 , C07D409/14 , A61K31/41 , A61K31/454 , A61P31/10
CPC分类号: A61K31/21 , A61K31/41 , C07D405/04
摘要: Novel derivatives of enfumafungin are disclosed herein, along with' their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and method of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.
摘要翻译: 本文公开了enfumafungin的新型衍生物以及“其药学上可接受的盐,水合物和前药”。 还公开了包含这种化合物的组合物,制备这些化合物的方法和使用这些化合物作为抗真菌剂和/或(1,3) - &bgr-D-葡聚糖合酶抑制剂的方法。 所公开的化合物,其药学上可接受的盐,水合物和前药,以及包含这些化合物,盐,水合物和前药的组合物可用于治疗和/或预防真菌感染和相关疾病和病症。
-
-
-